Medical treatments for incomplete miscarriage (less than 24 weeks)

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Neilson, James P ^a   Gyte, Gillian M L ^a   Hickey, Martha ^b   Vazquez, Juan C ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOMETRINE; GESTAGEN; MIFEPRISTONE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN F2 ALPHA;

ANEMIA; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; DEATH; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG SAFETY; FERTILITY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERTENSION; INCOMPLETE ABORTION; META ANALYSIS; PAIN; PELVIC INFLAMMATORY DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; SYSTEMATIC REVIEW;

EID: 55049100581     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007223     Document Type: Review

References (47)

1. Aleman 2005 Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003576.pub2]
2. Alfirevic 2006 Alfirevic Z, Weeks A. Oral misoprostol for induction of labour with a viable fetus. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001338.pub2]
3. Ankum 2001 Ankum WM, Wieringa-de Waard M, Bindels PJE. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ 2001;322:1343- 6.
4. Arthur 2007 Arthur P, Taggart MJ, Mitchell BF. Oxytocin and parturition: a role for increased myometrial calcium and calcium sensitization?. Frontiers in Bioscience 2007;12:619-33.
5. Bamigboye 2003 Bamigboye AA, Morris J. Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004353]
6. Costa 1993 Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993;341:1258-61.
7. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
8. Di Nisio 2005 Di Nisio M, Peters LW, Middeldorp S. Aspirin or anticoagulants for the treatment of recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: DOI: 10.1002/14651858.CD004734.pub2]
9. Dodd 2004 Dodd JM, Crowther CA. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD004901]
10. Empson 2005 Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002859.pub2]
11. Fonseca 1991 Fonseca W, Alencar AJC, Mota FSB, Coelho HLL. Misoprostol and congenital malformations. Lancet 1991;338:56.
12. Forna 2001 Forna F, Gülmezoglu AM. Surgical procedures to evacuate incomplete miscarriage. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001993]
13. Gates 2005 Gates S. Methodological Guidelines. In: the Editorial Team. Pregnancy and Childbirth Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, issue 2.
14. Gülmezoglu 2007 Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858. CD000494.pub3]
15. Harris 2007 Harris LH, Dalton VK, Johnson TRB. Surgical management of early pregnancy failure: history, politics, and safe, cost-effective care. American Journal of Obstetrics and Gynecology 2007;196(5):445.e1- 445.e5.
16. Hawk 1985 Hawk HW, Conley HH. Effect of prostaglandin F2 alpha, phenylephrine and ergonovine on uterine contractions in the ewe. Journal of Animal Science 1985;60(2):537-43.
17. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org..
18. Hofmeyr 2003 Hofmeyr GJ, Gülmezoglu AM. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858. CD000941]
19. Jain 2002 Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Human Reproduction 2002;17(6): 1477-82.
20. Kawarabayashi 1990 Kawarabayashi T, Kishikawa T, Sugimori H. Effect of methylergometrine maleate (methergin) on electrical and mechanical activities of pregnant human myometrium. Gynecologic and Obstetric Investigation 1990;24(4):246-9.
21. Klier 2002 Klier CM, Geller PA, Ritsher JB. Affective disorders in the aftermath of miscarriage: a comprehensive review. Archives of Women's Mental Health 2002;5:129-49.
22. Kulier 2004 Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002855.pub3]
23. Lede 2005 Lede R, Duley L. Uterine muscle relaxant drugs for threatened miscarriage. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD002857.pub2]
24. Lewis 2007 Lewis G, editor. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
25. Lohr 2008 Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006714.pub2]
26. Lok 2007 Lok IH, Neugebauer R. Psychological morbidity following miscarriage. Best Practice & Research. Clinical Obstetrics & Gynaecology 2007;21(2):229-47.
27. Luise 2002 Luise C, Jermy K, May C, Costello G, Collins WP, Bourne TH. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ 2002;324:873-5.
28. Medema 2005 Medema S, Wildschut HIJ, Van Gemund N, Scherjon SA. Medical methods for mid-trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005216]
29. Mota-Rojas 2007 Mota-Rojas D, Villanueva-García D, Velazquez-Armenta EY, Nava-Ocampo AA, Ramírez-Necoechea R, Alonso-Spilsbury M, et al.Influence of time at which oxytocin is administered during labor on uterine activity and perinatal death in pigs. Biological Research 2007;40(1):55-63.
30. Nanda 2006 Nanda K, Peloggia A, Grimes D, Lopez L, Nanda G. Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003518.pub2]
31. Neilson 2006 Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD002253.pub3]
32. Norman 1991 Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-6.
33. Oates-Whitehead 2003 Oates-Whitehead RM, Haas DM, Carrier JAK. Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003511]
34. Porter 2006 Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD000112.pub2]
35. Ramphal 2006 Ramphal SR, Moodley J. Emergency gynaecology. Best Practice & Research. Clinical Obstetrics & Gynaecology 2006;20(5):729-50.
36. RCOG 2006 RCOG. The management of early pregnancy loss. Royal College of Obstetricians and Gynaecologists, Guideline No. 25. London: RCOG, 2006.
37. RevMan 2008 The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
38. Rumbold 2005 Rumbold A, Middleton P, Crowther CA. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: DOI: 10.1002/14651858.CD004073.pub2]
39. Sawyer 2007 Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound in Obstetrics & Gynecology 2007;29(2):205-9.
40. Say 2002 Say L, Kulier R, Gülmezoglu M, Campana A. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2]
41. Shiers 2003 Shiers C. Abnormalities of early pregnancy. In: Fraser DM, Cooper MA editor(s). Myles textbook for midwives. 14th Edition. Edinburgh: Churchill Livingstone, 2003.
42. Swanson 1999 Swanson KM. Effects of caring, measurement, and time on miscarriage impact and women's well-being. Nursing Research 1999;48(6):288-98.
43. Tang 2006 Tang OS, Ho PC. The use of misoprostol for early pregnancy failure. Current Opinion in Obstetrics and Gynecology 2006;18(6):581-6.
44. Thapar 1992 Thapar AK, Thapar A. Psychological sequelae of miscarriage: a controlled study using the general health questionnaire and the hospital anxiety and depression scale. British Journal of General Practice 1992;42(356):94-6.
45. Wahabi 2007 Wahabi HA, Abed Althagafi NF, Elawad M. Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD005943.pub2]
46. Weeks 2001 Weeks A, Alia G. Ultrasonography may have role in assessing spotaneous miscarriage. BMJ 2001;323:694.
47. Zieman 1997 Zieman M, Fong SK, Benowitz NL, Bankster D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics & Gynecology 1997;90:88-92.